In addition, the mammalian target of rapamycin (mTOR) pathway was down-regulated by NR in class 1 clusters, correlating with NR’s role in autophagy/mitophagy induction (21, 65); this could ameliorate AD pathology and symptoms (66). The gene discussed is MTOR; the disease is Alzheimer disease.